Black Hawk Acquisition M&A Deal with Vesicor Therapeutics, Inc.
Black Hawk Acquisition Corporation shareholders approved its business combination with Vesicor Therapeutics, Inc. at an extraordinary general meeting. The approval includes the domestication of the company from the Cayman Islands to Delaware and the election of five directors to the post-combination board. This represents a status update on a pending merger as the SPAC moves toward closing the transaction.
- Counterparty
- Vesicor Therapeutics, Inc.